12-hydroxyibogamine
From: CallieMimosa@aol.com Subject: Re: [Ibogaine] Nick Date: December 31, 2005 at 11:40:23 PM EST To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com In a message dated 12/31/2005 9:45:56 PM Central Standard Time, captkirk@clear.net.nz writes: Should i stop communicating as Capt KIrk? ;o) does it really matter? As long as you are not a Klingon…
From: Kirk <captkirk@clear.net.nz> Subject: RE: [Ibogaine] protein and mushrooms Date: August 1, 2005 at 12:03:53 AM EDT To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com What I think he’s trying to tell us is that…..um….no scratch that, I have no idea what he’s on about. Such a cryptic person non? Never know what he’s…
From: tink <tinkerbell.sarah@gmail.com> Subject: Re: [Ibogaine] Vascular Trouble Date: June 1, 2005 at 12:16:24 AM EDT To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com thankyou for that clarity. We never would’ve figured it out. :] tink(sick fux inc) On 5/31/05, Schmoolyboy@aol.com <Schmoolyboy@aol.com> wrote: The Fang are also not tweeked sick junkies who abused their…
From: HSLotsof@aol.com Subject: Re: [Ibogaine] Carla, re: George Bush, the fascist capitalist dictator from Texas Date: October 31, 2004 at 9:07:14 PM EST To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com Ibogaine is not a cure. It is a highly effective treatment. It is about as good as it gets unless you opt for…
From: CrookedEye420@aol.com Subject: Re: [ibogaine] Sara’s web site down?help needed Date: June 30, 2004 at 11:56:50 PM EDT To: ibogaine@mindvox.com Reply-To: ibogaine@mindvox.com In a message dated 6/24/2004 12:11:42 AM Eastern Daylight Time, HSLotsof@aol.com writes: The web page is missing as are the search engine citations. There used to be a…
Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to…
18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…
the Deborah Mash Interview with Paul DeRienzo Dr. Deborah Mash is a faculty member in the Department of Neurology of the University of Miami, School of Medicine with a secondary appointment in Cellular Molecular Pharmacology. Dr. Mash’s area of expertise is called Neuropharmacology and Neuroscience and her doctoral dissertation was…
Ibogaine: A Novel Anti-Addictive Compound A Comprehensive Literature Review By: Jonathan Freedlander Advisor: Carlo DiClemente, Ph.D. University of Maryland, Baltimore County Introduction and History Ibogaine is a naturally occurring indole alkaloid, found in a variety of African shrubs of the Tabernanthe genus (Obach, Pablo, and Mash, 1998). The root of…
maps • volume xv number 1 • Spring 2005 By Patrick K. Kroupa & Hattie Wells History The history of using ibogaine to break the cycle of drug-dependence is relatively short. While it is likely that the CIBA pharmaceutical company and the US government were aware of ibogaine’s anti-addictive properties…